Helping Patients in Addiction Treatment Stay Connected During the COVID-19 Pandemic (NAM - ASAM Collaboration)
-
Register
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
Helping Patients in Addiction Treatment Stay Connected During the COVID-19 Pandemic (NAM-ASAM)
As the leader in developing clinical guidelines and standards in addiction medicine, ASAM takes its responsibility very seriously. Many providers and programs are urgently working to mitigate risks related to COVID-19. This joint NAM-ASAM session provides an overview of increasing COVID-19 resources and discusses evolving guidance to inform your practices during the pandemic.
This session is part of the ASAM-NAM series, "Supporting Addiction Treatment During COVID-19" and this webinar is part 1 of the 3 part series.
Original Recording Information
Date: Thursday, May 7, 2020
Time: 11:00 am ET / 10:00 am CT/ 8:00 am PT
Speakers:
- Kelly Clark, MD, MBA
- Brian Hurley, MD, MBA
- Chris Bundy, MD, MPH
- Cortney Lovell, CRPA, CARC, RCP
Learning Objectives
By completing this webinar, you will be able to:
- Discuss unique challenges to substance use treatment providers and patients during the COVID-19 pandemic
- Recognize patient-centered strategies for maintaining access to addiction treatment
- Identify recent changes to telehealth regulations, payment, and clinical guidance related to access to medications and support groups
- Describe strategies to ensure patients remain connected with their providers, treatment and recovery plans during the COVID-19 pandemic
Kelly Clark (Moderator)
MD, MBA, DFASAM, DFAPA
Dr. Kelly J. Clark is the immediate past President Elect of ASAM. She currently chairs the Public Policy Council, consisting of the Legislative Advocacy, Payer Relations, and Public Policy Committees.
Board certified in addiction medicine and psychiatry, she has focused her career on issues of prescription drug abuse, evidence informed behavioral health care, and payment reform. Dr. Clark is Chief Medical Officer of CleanSlate Centers, a multi-state medical group currently treating over 5,000 opioid addicted patients with medication management, and which has received a SAMHSA Science to Service Award for Office Based Opioid Treatment. She is active on the Association of Managed Care Pharmacy's Addiction Treatment Advisory Group; served on the writing committee of the Johns Hopkins Bloomberg School of Public Health's recent policy document, “The Prescription Drug Epidemic: An Evidence Based Approach”; and led the workgroup on Health Systems and Reimbursement at SAMHSA's Buprenorphine Summit.
As the Behavioral Health Medical Director of CDPHP, a non-profit health plan in New York, she provided the clinical leadership for in-sourcing the management of behavioral health benefits. As Chief Medical Officer for Behavioral Health Group, she again focused on opioid addiction. Her expertise in payment models, quality metrics, medical-behavioral health integration, and clinical care delivery systems, as well as her clinical work treating people with addictive disease, all allow her to offer insights and recommendations to address the current epidemic.
As faculty of the University of Massachusetts Medical School for eight years, Dr. Clark trained students and resident physicians on addiction. She is currently a member of the American Psychiatric Association's Integrated Care Work Group; the National Rx Drug Abuse Summit Advisory Board; and the faculty of the Virginia Tech Carilion School of Medicine.
Brian Hurley
MD, MBA, DFASAM
Los Angeles Country Department of Health Services
Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. As Director-at-Large, Brian currently serves as a board member of ASAM and gives presentations around the world regarding addiction medicine. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Treatment Starts Here program through the Center for Clinical Innovation, focused on increasing the delivery of medications for addiction treatment in California’s community health centers.
He is a senior researcher at the Friends Research Institute and is a primary investigator on a Tobacco Related Disease Prevention Program-funded project integrating smoking cessation services into community mental health centers and patient-centered medical homes and is the grant lead for three Medications for Addiction Treatment Access Points projects funded by the Sierra Health Foundation supporting access to medications for addiction treatment across Los Angeles County.
He is also a co-investigator for several Rand Corporation projects evaluating the integration of substance use disorder treatment within community mental health and Federally Qualified Health Center settings. He also serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry Examination Writing Committee. Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA) and is an alumnus of the Massachusetts General Hospital and McLean Hospital Psychiatry Residency Training Program and the New York University Addiction Psychiatry Fellowship. Additionally, he has served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.
No Relevant Financial Disclosures
Chris Bundy, MD, MPH
Executive Medical Director, Washington Physicians Health Program
Dr. Bundy is the Executive Medical Director of the Washington Physicians Health Program (WPHP), President of the Federation of State Physician Health Programs and Clinical Associate Professor of Psychiatry, University of Washington School of Medicine. Prior to joining WPHP, he served as Mental Health Service Chief and Chief of Psychiatry at the VA Puget Sound Healthcare System. Dr. Bundy draws on his experience as a health-care leader, medical educator, and recovering physician to support education and advocacy efforts related to physician health and wellbeing.
Cortney Lovell, CRPA, CARC, RCP
Recovery Coach, and Co-Founder, Our Wellness Collective
Widely regarded as one of the world’s top leaders in Recovery Coaching, Cortney Lovell is a modern messenger for change. Driven by her personal experience of growth and transformation, study and reflection, she is challenging traditional treatment systems to truly meet individuals who use drugs where they are, with the support they need. Cortney co-founded Our Wellness Collective and RecoveryTraining.Online to better support the growing recovery profession. She currently serves on the Health and Human Services Advisory Committee for Women’s Services, National Academy of Medicine’s Opioid Collaborative, is the Director of Cross Systems Education for Families Together in New York State and a regular addiction media correspondent.
Credits and Disclosures
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The National Academy of Medicine (NAM). The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
CME Reviewer and Disclosure Information
ASAM CME Committee Reviewer
The ASAM COVID-19 Review Team
Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
ACCME’s Policy For Disclosures During The COVID-19 Pandemic
Per ACCME’s simplified process for COVID-19, the requirement of disclosure of relevant financial relationships and resolution of personal conflicts of interest has been removed. Currently, there are no FDA-approved vaccines or treatments for COVID-19. Hence, there is no possibility of a relevant financial relationship that would create a conflict of interest.
Faculty and Panelists
Kelly J. Clark, MD, MBA
Immediate Past President, American Society of Addiction Medicine
Elizabeth Finkelman, MPP
Director, Action Collaborative on Countering the U.S. Opioid Epidemic, National Academy of Medicine
Brian Hurley, MD, MBA
Director of Addiction Medicine, Los Angeles County Department of Health Services
Chris Bundy, MD, MPH
Executive Medical Director, Washington Physicians Health Program
Cortney Lovell, CRPA, CARC, RCP
Recovery Coach and Co-Founder, Our Wellness Collective
Key:
Complete
Next
Failed
Available
Locked